Tizanidine HCl (Generic Zanaflex) - Uses, Dosage and Side EffectsTizanidine Hydrochloride is a drug that is used as a muscle relaxant. It is used to treat the spasms, cramping, and tightness of muscles caused by medical problems such as multiple sclerosis, spastic diplegia, back pain, or certain other injuries to the spine or central nervous system. It is also prescribed off-label for migraine headaches, as a sleep aid, and as an anticonvulsant. It is also prescribed for some symptoms of fibromyalgia. Tizanidine Hydrochloride (Generic Zanaflex) - Availability And PackagingTizanidine Hydrochloride is available under the brand names Zanaflex Tablets and Sirdalud Tablets which is packaged 2 and 4 mg tablets for oral administration. Tizanidine is also supplied in gel cap form in doses of 2 mg, 4 mg, and 6 mg. The tablets are composed of the active ingredient, tizanidine hydrochloride (2.288 mg equivalent to 2 mg tizanidine base and 4.576 mg equivalent to 4 mg tizanidine base), and the inactive ingredients, silicon dioxide colloidal, stearic acid, microcrystalline cellulose and anhydrous lactose. Side Effects of Tizanidine HCl (Generic Zanaflex)Tizanidine Hydrochloride can possibly cause the following side effects: Drowsiness, dry mouth with increased dosage, dizziness. Tizanidine Hydrochloride - DosageIt is recommended to begin treatment with single oral doses of 4 mg and increase the dose gradually (2 to 4 mg steps) to optimum effect (satisfactory reduction of muscle tone at a tolerated dose). Tizanidine Hydrochloride - InteractionsConcomitant use of tizanidine and moderate or potent CYP1A2 inhibitors is contraindicated. Concomitant use of tizanidine with fluvoxamine, a potent CYP1A2 inhibitor in man, resulted in a 33-fold increase in the tizanidine AUC (plasma drug concentration-time curve) by fluvoxamine. Tizanidine is a potent sedative. It therefore has the potential, to interact with other CNS depressants. Alcohol should obviously be avoided, particularly as it can cause stomach upset. Additional InformationAdditional Info: Prescribing Information
|
| Last Updated on Saturday, 06 August 2011 08:49 |